Financial Statements
United Overseas Insurance revenue rises 6% YoY in Q1’24
United Overseas Insurance revenue rises 6% YoY in Q1’24
The company saw its net earnings reach $8m during the quarter.
Chubb witnesses 13.3% net income surge in Q1’24
The group saw strong results in its commercial and consumer P&C and Asia life businesses.
Ping An’s profit dips in Q1’24
Earnings per share were down 4.6% for the quarter.
Marsh McLennan Q1’24 revenue up 9% to $6.5b
Marsh’s APAC business saw its revenue jump 6% YoY.
ICICI Lombard's GDPI climbs 17.8% in FY’24
Its Q4’24 earnings were driven by motor and health segments.
Lloyd’s sees 11.6% gross written premiums surge in 2023
Its overall profit before tax stood at $13.5b.
HDI Global SE’s insurance revenue soars 10% YoY in FY'23
Its Singapore business expanded its product offering through political and credit risk market entry.
Prudential's new business profit jumps 45% YoY
Prudential’s CEO is optimistic about reaching its 2027 financial and strategic objectives.
FWD Group sees 22% YoY surge in new business value for 2023
Operating profit surged 27% YoY to $372m.
AIA records double-digit profit growth in 2023
Mainland China, Hong Kong, ASEAN (except Vietnam and India) also registered double-digit growth.
MS Amlin rebounds in 2023
The (re)insurer registered a net loss of $60m in 2022.
Great Eastern profit attributable to shareholders grew 21% in Q3
It increased to $180.2m.
UOI net profit up 70.2% in H1 due to favourable investment markets
United Overseas Investment Limited (UOI) posted $12.15m net profit.
Thought Leadership Centre
In Association with
Most Read
1. Hong Kong regulator guts insurance referral fees with 50% cap 2. HSBC says 'no decision' made in Singapore insurance review 3. Can China’s $140b motor insurance market survive a 70% loss ratio? 4. TS Holdings merges Shin Kong Life and Taishin Life 5. PNB MetLife launches dividend fund linked to insuranceResource Center
Read Here
Advertise
Sign Up
Awards
Jul
07
Events
Event News
28 March left over 5,300 dead yet coverage was negligible in Myanmar due to under 5% uptake.
